Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment

Genes Chromosomes and Cancer

Volumn 37, Issue 1, 2003, Pages 1-19

  Sirvent, Nicolas ^a   Maire, Georges ^a   Pedeutour, Florence ^a,b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGE; AGED; ALPHA HELIX; AUTOCRINE EFFECT; BEDNAR TUMOR; CHROMOSOME 17Q; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DERMATOFIBROSARCOMA PROTUBERANS; EXON; FEMALE; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DOSAGE; GIANT CELL; GRANULE CELL; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RING CHROMOSOME;

ANIMALS; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; ENZYME INHIBITORS; HUMANS; RING CHROMOSOMES; SKIN NEOPLASMS; SRC-FAMILY KINASES;

EID: 0037402488     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10202     Document Type: Review

References (110)

1. Abenoza P, Lillemoe T. 1993. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 15:429-434.
2. Allen PW, Zwi J. 1992. Giant cell fibroblastoma transforming into dermatofibrosarcoma protuberans. Am J Surg Pathol 16:1127-1129.
3. Altman DA, Nickoloff BJ, Fivenson DP. 1993. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 20:154-158.
4. Annessi G, Cimitan A, Girolomoni G, Giannetti A. 1993. Congenital dermatofibrosarcoma protuberans. Pediatr Dermatol 10:40-42.
5. Ballo MT, Zagars GK, Pisters P, Pollack A. 1998. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 40:823-827.
6. Banerjee SS, Harris M, Eyden BP, Hamid BN. 1990. Granular cell variant of dermatofibrosarcoma protuberans. Histopathology 17: 375-378.
7. Barr FG, Nauta LE, Davis RJ, Schäfer BW, Nycum MN, Biegel JA. 1996. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 5:15-21.
8. Bednar B. 1957. Storiform neurofibromas of the skin, pigmented and non-pigmented. Cancer 10:368-376.
9. Bendix-Hansen K, Myhre-Jensen O, Kaae S. 1983. Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature. Scand J Plast Reconstr Surg 17:247-252.
10. Bouyssou-Gauthier ML, Labrousse F, Longis B, Bedane C, Bernard P, Bonnetblanc JM. 1997. Dermatofibrosarcoma protuberans in childhood. Pediatr Dermatol 14:463-465.
11. Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ. 2000. Dermatofibrosarcoma protuberans; a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 88:2711-2720.
12. Bridge JA, Neff JR, Sandberg AA. 1990. Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49: 199-202.
13. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG, Druker BJ. 1997. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 90:4947-4952.
14. Checketts SR, Hamilton TK, Baughman RD. 2000. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol 42:907-913.
15. Chu M-L, Prockop DJ. 1993. Collagen: gene structure. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley-Liss. p 149-165.
16. Chung EB. 1985. Pitfalls in diagnosing benign soft tissue tumors in infancy and childhood. Pathol Annu 2:323-386.
17. Connelly JH, Evans HL. 1992. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 16:921-925.
18. Coyne J, Kaftan SM, Craig RD. 1992. Dermatofibrosarcoma protuberans recurring as a giant cell fibroblastoma. Histopathology 21:184-187.
19. Craver RD, Correa H, Kao Y, Van Brunt T. 1995a. Dermatofibrosarcoma protuberans with 46, XY, t(X;7) abnormality in a child. Cancer Genet Cytogenet 80:75-77.
20. Craver RD, Correa H, Kao YS, Van Brunt T, Golladay ES. 1995b. Aggressive giant cell fibroblastoma with a balanced 17;22 translocation. Cancer Genet Cytogenet 80:20-22.
21. Cribier B, Noacco G, Peltre B, Grosshans E. 2002. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol 46:408-413.
22. Dal Cin P, Sciot R, de Wever I, Brock P, Casteels-Van Daele M, Van Damme B, Van Den Berghe H. 1996. Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 15:73-75.
23. Dal Cin P, Polito P, Van Eyken P, Sciot R, Hernandez JM, Garcia JL, Van den Berghe H. 1997. Anomalies of chromosomes 17 and 22 in giant cell fibroblastoma. Cancer Genet Cytogenet 97:165-166.
24. Dalgleish R. 1997. The human type I collagen mutation database. Nucleic Acids Res 25:181-187.
25. Darier J, Ferrand NI. 1924. Dermatofibrosarcomes progressifs et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiligr 5:545-562.
26. David V, Preaux J. 1968. Darier-Ferrand dermatofibrosarcoma in children. Bull Soc Fr Dermatol Syphiligr 75:187-188.
27. Devare SG, Reddy EP, Law JD, Robbins KC, Aaronson SA. 1983. Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci USA 80:731-735.
28. Ding J, Hashimoto H, Enjoji M. 1989. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors. Cancer 64:721-729.
29. Ding JA, Hashimoto H, Sugimoto T, Tsuneyoshi M, Enjoji M. 1990. Bednar tumor (pigmented dermatofibrosarcoma protuberans). An analysis of six cases. Acta Pathol Jpn 40:744-754.
30. Dobin SM, Diaz JA, Silva MT, Truss LM, Donner LR. 1999. Translocation (17;22)(q22;q13) in a case of subcutaneous dermatofibrosarcoma protuberans in an adult. Cancer Genet Cytogenet 109:86-87.
31. Druker BJ, Lydon NB. 2000. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 105:3-7.
32. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561-566.
33. Dupree WB, Langloss JM, Weiss SW. 1985. Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 9: 630-639.
34. Enzinger FM, Weiss SW. 1995. Soft tissue tumors, Second Ed. St. Louis: Mosby.
35. Funa K, Ahgren A. 1997. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA. Cell Growth Differ 8:861-869.
36. Gisselsson D, Hoglund M, O'Brien KP, Dumanski JP, Merrens F, Mandahl N. 1998. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences. Cancer Lett 133:129-134.
37. Gloster HM Jr. 1996. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35:355-374.
38. Goldblum JR. 1995. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch Pathol Lab Med 119:238-241.
39. Goldblum JR, Tuthill RJ. 1997. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol 19:147-153.
40. Goldblum JR, Reith JD, Weiss SW. 2000. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol 24:1125-1130.
41. Greco A, Fusetti L, Villa R, Sozzi G, Minoletti F, Mauri P, Pierotti MA. 1998. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene 17:1313-1319.
42. Greco A, Roccato E, Miranda C, Cleris L, Formelli F, Pierotti MA. 2001. Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement. Int J Cancer 92:354-360.
43. Hamada M, Hirakawa N, Fukuda T, Furue M, Hori Y, Tsuneyoshi M. 1999. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations. Pathol Res Pract 195:451-460.
44. Heldin CH, Eriksson U, Ostman A. 2002. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 398:284-290.
45. Hoffmann E. 1925. Über das Knollentribende Fibrosarkom der Haut (Dermatofibrosarkoma Protuberans). Dermatol Z 43:1-28.
46. Huether MJ, Zitelli JA, Brodland DG. 2001. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 44:656-659.
47. Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Fujita C, Kaneko Y, Kikuchi M, Shinohara N. 1998. Supernumerary ring chromosomes and nuclear blebs in some low-grade malignant soft tissue tumours: atypical lipomatous tumours and dermatofibrosarcoma protuberans. Virchows Arch 432:521-528.
48. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
49. Kaburagi Y, Hatta N, Kawara S, Takehara K. 1998. Pigmented dermatofibrosarcoma protuberans (Bednar tumor) occurring in a Japanese infant. Dermatology 197:48-51.
50. Kagoura NI, Toyoda M, Nagahori H, Makino T, Morohashi M. 1999. An ultrastructural and immunohistochemical study of pigmented dermatofibrosarcoma protuberans (Bednar tumor). Eur J Dermatol 9:366-369.
51. Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J, Kere J, Miettinen M, Knuutila S. 2001. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 92:192-195.
52. Kobayashi T, Hasegawa Y, Konohana A, Nakamura N. 1997. A case of Bednar tumor. Immunohistochemical positivity for CD34. Dermatology 195:57-59.
53. Kransdorf MJ. 1995. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. Am J Roentgenol 164:129-134.
54. Kutzner H. 1993. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 28:613-617.
55. Le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F, Gambacorti-Passerini C. 1999. In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J Natl Cancer Inst 91:163-168.
56. Lever WF. 1990. Histopathology of the skin, Seventh Ed. Philadelphia: Lippincott.
57. Liu YC, Chen SC, Chang C, Leu CM, Hu CP. 1996. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp Cell Res 228:206-211.
58. Maire G, Martin L, Michalak-Provost S, Gattas GJ, Turc-Carel C, Lorette G, Pedeutour F. 2002a. Fusion of COL1A1 exon 29 with PDGFB exon 2 in a der(22)t(17;22) in a pediatric giant cell fibroblastoma with a pigmented Bednar tumor component. Evidence for age-related chromosomal pattern in dermatofibrosarcoma protuberans and related tumors. Cancer Genet Cytogenet 134:156-161.
59. Maire G, Pedeutour F, Coindre JM. 2002b. COL1A1-PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. Am J Surg Pathol 26:932-937.
60. Maire G, Pedeutour F, Mrozek K, Rys J, Iliszko M, Limon J. 2002c. COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans. Molecular analysis of a case with an unusual large marker containing sequences from chromosomes 7, 8, 17, 21, and 22. Cancer Genet Cytogenet 135:197-199.
61. Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. 2002, Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 100:623-626.
62. Mandahl N, Heim S, Willen H, Rydholm A, Mitelman F. 1990. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49:273-275.
63. Mandahl N, Limon J, Mertens F, Arheden K, Mitelman F. 1996. Ring market containing 17q and chromosome 22 in a case of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 89: 88-91.
64. Marini M, Saponaro A, Magarinos G, de Baldrich A, Lynch P, Remorino L. 2001. Congenital atrophic dermatofibrosarcoma protuberans. Int J Dermatol 40:448-450.
65. Martin L, Combemale P, Dupin M, Chouvet B, Kanitakis J, Bouyssou-Gauthier ML, Dubreuil G, Claudy A, Grimand PS. 1998. The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol 139:719-725.
66. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. 1998. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 22:576-587.
67. Michal M, Zamecnik M. 1992. Giant cell fibroblastoma with a dermatofibrosarcoma protuberans component. Am J Dermatopathol 14:549-552.
68. Minoletti F, Miozzo M, Pedeutour F, Sard L, Pilotti S, Azzarelli A, Turc-Carel C, Pierotti MA, Sozzi G. 1995. Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 13:62-65.
69. Mrozek K, Iliszko M, Rys J, Babinska M, Niezabitowski A, Bloomfield CD, Limon J. 2001. Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality. Genes Chromosomes Cancer 31:182-186.
70. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. 1995. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147:1553-1558.
71. Nakamura T, Ogata H, Katsuyama T. 1987. Pigmented dermatofibrosarcoma protuberans. Report of two cases as a variant of dermatofibrosarcoma protuberans with partial neural differentiation. Am J Dermatopathol 9:18-25.
72. Navarro M, Simon MP, Migeon C, Turc-Carel C, Pedeutour F. 1998. COL1A1-PDGFB fusion in a ring chromosome 4 found in a dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 23:263-266.
73. Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Yo S, Isayama T, Naito M, Kikuchi M. 2001. Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis. Genes Chromosomes Cancer 30:305-309.
74. O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP. 1998. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23:187-193.
75. Örndal C, Mandahl N, Rydholm A, Willen H, Brosjo O, Heim S, Mitelman F. 1992. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 60:170-175.
76. Östman A, Thyberg J, Westermark B, Heldin CH. 1992. PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly. J Cell Biol 118:509-519.
77. Pappo AS, Rao BN, Cain A, Bodner S, Pratt CB. 1997. Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude Children's Research Hospital. Pediatr Hematol Oncol 14:563-568.
78. Pedeutour F, Coindre JM, Nicolo G, Bouchot C, Ayraud N, Turc-Carel C. 1993. Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: fluorescence in situ hybridization. Cancer Genet Cytogenet 67:149.
79. Pedeutour F, Coindre JM, Sozzi G, Nicolo G, Leroux A, Toma S, Miozzo M, Bouchot C, Hecht F, Ayraud N, Turc-Carel C. 1994. Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet 76:1-9.
80. Pedeutour F, Simon MP, Minoletti F, Sozzi G, Pierotti MA, Hecht F, Turc-Carel C. 1995. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosomes 17 and 22 sequences. Cancer Res 55:2400-2403.
81. Pedeutour F, Lacour JP, Perrin C, Huffermann K, Simon MP, Ayraud N, Turc-Carel C. 1996a. Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 89:175-176.
82. Pedeutour F, Simon MP, Minoletti F, Barcelo G, Terrier-Lacombe MJ, Combemale P, Sozzi G, Ayraud N, Turc-Carel C. 1996b. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 72:171-174.
83. Penner DW. 1951. Metastasizing dermatofibrosarcoma protuberans. A case report. Cancer 4:1083-1086.
84. Rabinowitz LG, Luchetti ME, Segura AD, Esterly NB. 1994. Acrally occurring dermatofibrosarcoma protuberans in children and adults. J Dermatol Surg Oncol 20:655-659.
85. Robbins KC, Devare SG, Reddy EP, Aaronson SA. 1982. In vivo identification of the transforming gene product of simian sarcoma virus. Science 218:1131-1133.
86. Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, Bruckner JD. 2002. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofilbrosarcoma protuberans. J Clin Oncol 20:3586-3591.
87. Sandberg AA, Bridge JA. 2002. Update on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma. Cancer Genet Cytogenet 132:1-13.
88. Sheng WQ, Hashimoto H, Okamoto S, Ishida T, Meis-Kindblom JM, Kindblom LG, Hisaoka M. 2001. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. J Pathol 194:88-94.
89. Shimizu A, O'Brien KP, Sjöblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Östman A. 1999. The dermatofibrosarcoma protuberans-associated collagen type lalpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res 59:3719-3723.
90. Shmookler BM, Enzinger FM, Weiss SW. 1989. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 64:2154-2161.
91. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP. 1997. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95-98.
92. Simon MP, Navarro M, Roux D, Pouyssegur J. 2001. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans (DP). Oncogene 20:2965-2975.
93. Sinovic J, Bridge JA. 1994. Translocation (2;17) in recurrent dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 75:156-157.
94. Sonobe H, Furihata M, Iwata J, Ohtsuki Y, Chikazawa M, Taguchi T, Shimizu K. 1999. Dermatofibrosarcoma protuberans harboring t(9;22)(q32;q12.2). Cancer Genet Cytogenet 110:14-18.
95. Stenman G, Andersson H, Meis-Kindblom JM, Roijer E, Kindblom LG. 1995. FISH analysis of supernumerary ring chromosome in dermatofibrosarcoma protuberans. Int J Oncol 6:81-86.
96. Stephenson CF, Berger CS, Leong SP, Davis JR, Sandberg AA. 1992. Analysis of a giant marker chromosome in a well-differentiated liposarcoma using cytogenetics and fluorescence in situ hybridization. Cancer Genet Cytogenet 61:134-138.
97. Suit H, Spiro I, Mankin HJ, Efird J, Rosenberg AE. 1996. Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol 14:2365-2369.
98. Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, Huang EY, Lee SP. 2000. Dermatofibrosarcoma protuberans: treatment results of 35 cases. Radiother Oncol 57:175-181.
99. Taylor HB, Helwig EB. 1962. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer 15:717-725.
100. Taylor RW. 1890. Sarcomatous tumors resembling in some respects keloids. Arch Dermatol 8:384-387.
101. Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Ranchere Vince D, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM. 2003. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data. A study from the French Sarcoma Group. Am J Surg Pathol 27:27-39.
102. Tomasson MH, Williams IR, Hasserjian R, Udomsakdi C, McGrath SM, Schwaller J, Druker B, Gilliland DG. 1999. TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood 93:1707-1714.
103. Vanni R, Faa G, Dettori T, Melis GB, Dumanski JP, O'Brien KP. 2000. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma. Virchows Arch 437:95-100.
104. Wang J, Hisaoka M, Shimajiri S, Morimitsu Y, Hashimoto H. 1999. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 8:113-119.
105. Wang J, Morimitsu Y, Okamoto S, Hisaoka M, Ishida T, Sheng W, Hashimoto H. 2000. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans. J Mol Diagn 2:47-52.
106. Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin CH, Huang JS, Deuel TF. 1983. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304:35-39.
107. Weiss SW, Nickoloff BJ. 1993. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17:1039-1045.
108. Wick MR, Ritter JH, Lind AC, Swanson PE. 1999. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans. Semin Cutan Med Surg 18:91-98.
109. Wrotnowski U, Cooper PH, Shmookler BM. 1988. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol 12:287-293.
110. Zamecnik M, Michal M. 1994. Giant-cell fibroblastoma with pigmented dermatofibrosarcoma protuberans component. Am J Surg Pathol 18:736-740.